Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2018 > Volume 27 Number 1 January 2018 > CASE REPORTS > Use of AngioVac for Removal of Tricuspid Valve Vegetation

Use of AngioVac for Removal of Tricuspid Valve Vegetation

Peter Wallenhorst1, Joshua Rutland1, John Gurley1, Maya Guglin1,2

1University of Kentucky, Lexington, Kentucky, USA
2Electronic correspondence: mguglin@gmail.com
The use is reported of the AngioVac system to resolve a case of persistent bacteremia in the setting of MRSA tricuspid valve infective endocarditis. The infection was secondary to intravenous drug use in a patient who had failed multiple antibiotic regimens and was deemed a poor surgical candidate.

The Journal of Heart Valve Disease 2018;27:120-123


Use of AngioVac for Removal of Tricuspid Valve Vegetation

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.